The density and integrity of the angiogenic and morphologically aberrant tumor vasculature in GBM were assessed in cohorts of mice treated with anti-VEGF, IM + anti-VEGF, and IM + anti-VEGF + CDL. This evidence concerns the gene SGMS2 and neoplasm.